Quarterly Results Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Jun'26
Mar'26
Dec'25
Sep'25
Jun'25
Mar'25
Dec'24
Net Sales
1,064.15
923.03
1,021.17
1,031.65
1,060.47
956.07
949.81
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
1,064.15
923.03
1,021.17
1,031.65
1,060.47
956.07
949.81
Raw Material Cost
550.76
470.19
527.10
525.43
534.71
517.52
523.40
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.39
1.17
0.00
1.63
1.68
1.72
0.48
Selling and Distribution Expenses
174.61
172.03
183.47
212.66
195.46
191.76
131.22
Other Expenses
7.46
7.51
8.58
8.02
8.94
7.91
10.60
Total Expenditure (Excl Depreciation)
800.37
718.51
796.42
819.90
821.23
790.09
761.08
Operating Profit (PBDIT) excl Other Income
263.8
204.5
224.8
211.8
239.20000000000002
166
188.70000000000002
Other Income
29.29
10.78
21.71
26.14
35.68
33.90
51.66
Operating Profit (PBDIT)
314.92
267.33
263.57
289.85
344.86
281.01
291.66
Interest
0.39
1.17
0.00
1.63
1.68
1.72
0.48
Exceptional Items
-17.64
0.94
9.40
0.00
0.00
0.07
-43.26
Gross Profit (PBDT)
513.39
452.84
494.07
506.22
525.76
438.55
426.41
Depreciation
75.73
75.73
73.57
73.57
86.13
86.13
79.74
Profit Before Tax
221.16
191.37
199.41
214.65
257.05
193.22
168.17
Tax
31.36
25.22
14.16
25.44
30.22
27.83
28.95
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
186.42
165.20
182.37
187.73
224.59
163.29
136.95
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
186.42
165.20
182.37
187.73
224.59
163.29
136.95
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
3.38
0.95
2.88
1.48
2.24
2.09
1.62
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
189.80
166.15
185.25
189.21
226.82
165.38
138.57
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
6,000.30
6,093.89
5,833.04
5,651.37
5,463.48
5,689.53
5,969.51
Earnings per share (EPS)
0.23
0.2
0.22
0.23
0.28
0.2
0.16
Diluted Earnings per share
0.23
0.2
0.22
0.23
0.28
0.2
0.16
Operating Profit Margin (Excl OI)
19.72%
19.59%
16.48%
18.43%
21.03%
16.84%
16.87%
Gross Profit Margin
27.9%
28.94%
26.73%
27.94%
32.36%
29.22%
26.1%
PAT Margin
17.52%
17.9%
17.86%
18.2%
21.18%
17.08%
14.42%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - QoQ
Net Sales
QoQ Growth in quarter ended Jun 2026 is 15.30% vs -9.62% in Mar 2026
Consolidate Net Profit
QoQ Growth in quarter ended Jun 2026 is 14.20% vs -10.31% in Mar 2026
Operating Profit (PBDIT) excl Other Income
QoQ Growth in quarter ended Jun 2026 is 11.35% vs 6.04% in Mar 2026
Interest
QoQ Growth in quarter ended Jun 2026 is -66.67% vs 0.00% in Mar 2026
Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Jun 2026 has improved from Mar 2026
Compare Quarterly Results Of Zhejiang Jingxin Pharmaceutical Co., Ltd. With
Figures in Million
Consolidate Quarterly Results
Change(CNY)
Change(%)
Net Sales
1,064.15
0
1,064.15
Other Operating Income
0.00
0.00
0.00
Total Operating income
1,064.15
0
1,064.15
Raw Material Cost
550.76
0
550.76
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
0.39
0
0.39
Selling and Distribution Expenses
174.61
0
174.61
Other Expenses
7.46
0.00
7.46
Total Expenditure (Excl Depreciation)
800.37
0
800.37
Operating Profit (PBDIT) excl Other Income
263.78
0.00
263.78
Other Income
29.29
0
29.29
Operating Profit (PBDIT)
314.92
0
314.92
Interest
0.39
0
0.39
Exceptional Items
-17.64
0
-17.64
Gross Profit (PBDT)
513.39
0
513.39
Depreciation
75.73
0
75.73
Profit Before Tax
221.16
0
221.16
Tax
31.36
0
31.36
Provisions and contingencies
0
0
0.00
Profit After Tax
186.42
0
186.42
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
186.42
0
186.42
Share in Profit of Associates
0
0
0.00
Minority Interest
3.38
0
3.38
Other related items
0.00
0.00
0.00
Consolidated Net Profit
189.80
0
189.80
Equity Capital
0
0
0.00
Face Value
1.00
0
0.00
Reserves
6,000.30
0
6,000.30
Earnings per share (EPS)
0.23
0
0.23
Diluted Earnings per share
0.23
0
0.23
Operating Profit Margin (Excl OI)
19.72%
0%
0.00
19.72%
Gross Profit Margin
27.90%
0%
0.00
27.90%
PAT Margin
17.52%
0%
0.00
17.52%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 106.42 Million
in Jun 2026Figures in Million
QoQ Growth in quarter ended Jun 2026 is 15.30% vs -9.62% in Mar 2026
YoY Growth in quarter ended Jun 2026 is 0.35% vs -2.64% in Jun 2025
Quarterly - Consolidate Net Profit
Consolidate Net Profit 18.98 Million
in Jun 2026Figures in Million
QoQ Growth in quarter ended Jun 2026 is 14.20% vs -10.31% in Mar 2026
YoY Growth in quarter ended Jun 2026 is -16.31% vs -2.54% in Jun 2025
Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 28.56 Million
in Jun 2026Figures in Million
QoQ Growth in quarter ended Jun 2026 is 11.35% vs 6.04% in Mar 2026
YoY Growth in quarter ended Jun 2026 is -7.63% vs 16.55% in Jun 2025
Quarterly - Interest
Interest 0.04 Million
in Jun 2026Figures in Million
QoQ Growth in quarter ended Jun 2026 is -66.67% vs 0.00% in Mar 2026
YoY Growth in quarter ended Jun 2026 is -76.47% vs -29.17% in Jun 2025
Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 19.72%
in Jun 2026Figures in %
QoQ Growth in quarter ended Jun 2026 has improved from Mar 2026
YoY Growth in quarter ended Jun 2026 has fallen from Jun 2025
Footer loading
